Koninklijke Philips Basic EPS 2010-2024 | PHG
Koninklijke Philips annual/quarterly basic eps history and growth rate from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Koninklijke Philips basic eps for the quarter ending September 30, 2024 was $0.21, a 903.85% decline year-over-year.
- Koninklijke Philips basic eps for the twelve months ending September 30, 2024 was $0.01, a 98.91% decline year-over-year.
- Koninklijke Philips annual basic eps for 2023 was $-0.001B, a 71.22% decline from 2022.
- Koninklijke Philips annual basic eps for 2022 was $-0.002B, a 144.17% decline from 2021.
- Koninklijke Philips annual basic eps for 2021 was $0.004B, a 190.24% increase from 2020.
| Koninklijke Philips Annual Basic EPS | |
|---|---|
| 2023 | $-0.55 |
| 2022 | $-1.92 |
| 2021 | $4.34 |
| 2020 | $1.50 |
| 2019 | $1.45 |
| 2018 | $1.39 |
| 2017 | $2.01 |
| 2016 | $1.75 |
| 2015 | $0.78 |
| 2014 | $0.59 |
| 2013 | $1.70 |
| 2012 | $0.32 |
| 2011 | $-1.78 |
| 2010 | $2.09 |
| 2009 | $0.61 |
| Koninklijke Philips Quarterly Basic EPS | |
|---|---|
| 2024-09-30 | $0.21 |
| 2024-06-30 | $0.52 |
| 2023-06-30 | $0.09 |
| 2023-03-31 | $-0.81 |
| 2022-06-30 | $-0.03 |
| 2021-06-30 | $0.21 |
| 2020-06-30 | $0.25 |
| 2019-06-30 | $0.30 |
| 2018-06-30 | $0.00 |
| 2017-06-30 | $0.30 |
| 2016-12-31 | $0.74 |
| 2016-09-30 | $0.45 |
| 2016-06-30 | $0.52 |
| 2016-03-31 | $0.04 |
| 2015-12-31 | $-0.07 |
| 2015-09-30 | $0.39 |
| 2015-06-30 | $0.33 |
| 2015-03-31 | $0.12 |
| 2014-12-31 | $0.16 |
| 2014-09-30 | $-0.15 |
| 2014-06-30 | $0.37 |
| 2014-03-31 | $0.21 |
| 2013-12-31 | $0.59 |
| 2013-09-30 | $0.41 |
| 2013-06-30 | $0.46 |
| 2013-03-31 | $0.24 |
| 2012-12-31 | $-0.53 |
| 2012-09-30 | $0.24 |
| 2012-06-30 | $0.22 |
| 2012-03-31 | $0.35 |
| 2011-12-31 | $-0.23 |
| 2011-09-30 | $0.11 |
| 2011-06-30 | $-2.01 |
| 2011-03-31 | $0.20 |
| 2010-12-31 | $0.67 |
| 2010-09-30 | $0.71 |
| 2010-06-30 | $0.36 |
| 2010-03-31 | $0.30 |
| 2009-12-31 | $0.40 |
| 2009-09-30 | $0.27 |
| 2009-06-30 | $0.07 |
| 2009-03-31 | $-0.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $26.497B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.537B | 27.97 |
| Boston Scientific (BSX) | United States | $156.388B | 42.28 |
| Stryker (SYK) | United States | $146.977B | 31.60 |
| EssilorLuxottica (ESLOY) | France | $141.159B | 0.00 |
| Medtronic (MDT) | Ireland | $119.009B | 17.68 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.863B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.958B | 28.56 |
| GE HealthCare Technologies (GEHC) | United States | $42.167B | 20.54 |
| Agilent Technologies (A) | United States | $38.420B | 25.46 |
| ResMed (RMD) | United States | $34.217B | 26.35 |
| Terumo (TRUMY) | Japan | $26.961B | 38.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.011B | 12.56 |
| Insulet (PODD) | United States | $19.680B | 78.37 |
| Baxter (BAX) | United States | $15.736B | 10.24 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.236B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.837B | 36.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.760B | 26.88 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $4.260B | 20.33 |
| ICU Medical (ICUI) | United States | $3.921B | 37.33 |
| Envista Holdings (NVST) | United States | $3.723B | 29.62 |
| Perrigo (PRGO) | Ireland | $3.341B | 9.84 |
| Haemonetics (HAE) | United States | $3.133B | 14.74 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.963B | 19.97 |
| QuidelOrtho (QDEL) | United States | $2.729B | 22.92 |
| LeMaitre Vascular (LMAT) | United States | $2.218B | 53.91 |
| Neogen (NEOG) | United States | $2.133B | 24.58 |
| AtriCure (ATRC) | United States | $1.996B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.528B | 26.67 |
| InMode (INMD) | Israel | $1.308B | 10.94 |
| BioLife Solutions (BLFS) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.181B | 8.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.061B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.044B | 16.01 |
| Curaleaf Holdings (CURLF) | Canada | $0.978B | 0.00 |
| Evolus (EOLS) | United States | $0.933B | 0.00 |
| CeriBell (CBLL) | United States | $0.768B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.725B | 0.00 |
| Owens & Minor (OMI) | United States | $0.574B | 4.49 |
| VAREX IMAGING (VREX) | United States | $0.547B | 23.70 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Omeros (OMER) | United States | $0.532B | 0.00 |
| SNDL (SNDL) | Canada | $0.489B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
| ZimVie (ZIMV) | United States | $0.363B | 30.56 |
| Aurora Cannabis (ACB) | Canada | $0.346B | 63.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.346B | 0.00 |
| Cerus (CERS) | United States | $0.344B | 0.00 |
| Quanterix (QTRX) | United States | $0.310B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 29.00 |
| Canopy Growth (CGC) | Canada | $0.294B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.293B | 19.65 |
| Biote (BTMD) | United States | $0.249B | 5.45 |
| Zynex (ZYXI) | United States | $0.240B | 50.27 |
| INLIF (INLF) | $0.237B | 0.00 | |
| Sanuwave Health (SNWV) | United States | $0.229B | 3.21 |
| High Tide (HITI) | Canada | $0.214B | 0.00 |
| Brainsway (BWAY) | Israel | $0.213B | 113.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 15.46 |
| TerrAscend (TSNDF) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| MacroGenics (MGNX) | United States | $0.161B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
| Jin Medical (ZJYL) | China | $0.135B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 11.61 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Exagen (XGN) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.053B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.32 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |